We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NATR market cap is 366.97M. The company's latest EPS is USD 0.8011 and P/E is 24.27.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 104.51M | 102.75M | 108.63M | 116.55M | 111.2M |
| Operating Income | 5.01M | 4.18M | 172k | 7.04M | 5.83M |
| Net Income | 90k | 1.95M | 860k | 2.42M | 2.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 362.22M | 385.21M | 444.08M | 421.91M | 445.32M |
| Operating Income | 16.13M | 21.48M | 34.67M | 16.26M | 18.75M |
| Net Income | 6.77M | 21.34M | 28.85M | -390k | 15.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 223.51M | 229.78M | 234.58M | 236.15M | 239.91M |
| Total Liabilities | 81.75M | 82.73M | 87.87M | 86.75M | 87.9M |
| Total Equity | 141.75M | 147.05M | 146.72M | 149.4M | 152.01M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 213.07M | 249.5M | 258.87M | 229.78M | 249.77M |
| Total Liabilities | 83.63M | 92.26M | 97.47M | 82.73M | 90.23M |
| Total Equity | 129.44M | 157.23M | 161.4M | 147.05M | 159.54M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.87M | 710k | 9.33M | 17.26M | 31.63M |
| Investing | -4.73M | -7.63M | -2.33M | -4.75M | -9.23M |
| Financing | -15.31M | -16.25M | -1.16M | -1.81M | -3.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.55M | 37.66M | 34.61M | 710k | 41.23M |
| Investing | -5.1M | -4.91M | -6.61M | -7.63M | -10.48M |
| Financing | -63k | 3.88M | -31.72M | -16.25M | -7.96M |
| Market Cap | 366.97M |
| Price to Earnings Ratio | 24.27 |
| Price to Sales Ratio | 0.82 |
| Price to Cash Ratio | 4.44 |
| Price to Book Ratio | 2.29 |
| Dividend Yield | - |
| Shares Outstanding | 18.82M |
| Average Volume (1 week) | 41.33k |
| Average Volume (1 Month) | 44.25k |
| 52 Week Change | 82.41% |
| 52 Week High | 21.72 |
| 52 Week Low | 10.06 |
| Spread (Intraday) | 1.27 (6.27%) |
| Company Name | Natures Sunshine Products Inc |
| Address |
2901 west bluegrass blvd lehi, utah 84043 |
| Website | https://www.naturessunshine.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
